180 Degree Capital TURN 深 沪
已收盘 09-12 16:00:00 美东时间
4.96
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 4.96
- 总市值 4960.05万
- 52周最高 5.01
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.116
- 委 比 0.00%
- 总股本 1000.01万
- 历史最高 8.64
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.116
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多币圈每日动向 | 加密货币市场反弹，比特币站上11.5万美元关口；特朗普暗示加密货币或可解决35万亿美元的美国债务问题
10月27日消息，加密货币市场反弹，截至发稿，$比特币 (BTC.CC)$ 涨0.75%，报115544.50美元； $以太坊 (ETH.CC)$ 涨1.72...
10-27 14:21
每日数字货币动态汇总（2025-10-27）
1. 特朗普在私人聚会称加密货币或可解决35万亿美元的美国债务问题 据Bitcoinist报道，特朗普在一次私人聚会上表示加密货币“前景光明（great fu...
10-27 09:05
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
Turn Therapeutics will host a shareholder webinar on October 22, 2025, at 2:00 PM ET, to discuss execution milestones, pipeline progress, and capital strategy. The company highlights its flexible financing strategy following its direct listing, which preserves early shareholder ownership. Turn has secured an $85 million GEM Global Yield agreement for on-demand capital access. Its phase 2 trial of GX-03 for moderate to severe eczema is progressing...
10-22 12:00
Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025
Turn Therapeutics has launched a communication initiative including a webinar series and a Founder Blog by CEO Bradley Burnam to engage shareholders and the healthcare community. The blog will share company updates and insights, while the webinar series will discuss ongoing programs and developments, with the first session on October 22, 2025, at 2:00 PM ET. The company, focused on dermatology, wound care, and infectious disease, emphasizes innov...
10-20 12:22
President Trump Posts On Truth Social "ALL TWENTY HOSTAGES ARE BACK AND FEELING AS GOOD AS CAN BE EXPECTED. A big burden has been lifted, but the job IS NOT DONE. THE DEAD HAVE NOT BEEN RETURNED, AS PROMISED! Phase Two begins right NOW!!! "
https://truthsocial.com/@realDonaldTrump/posts/115373569028997850
10-15 01:01
Turn Therapeutics Appoints Arthur Golden to Board of Directors
Turn Therapeutics has appointed Arthur Golden to its Board of Directors. With decades of experience in corporate governance, M&A, and legal affairs, Golden will strengthen the Company's regulatory oversight and strategic execution, particularly during its late-stage clinical programs in dermatology and infectious diseases.
10-14 16:07
Turn Therapeutics to Commence Trading Today on Nasdaq
Turn Therapeutics, a clinical-stage biotechnology company, begins trading on the Nasdaq Capital Market on October 8, 2025, under the ticker symbol “TTRX.” Founder & CEO Bradley Burnam will ring the NASDAQ Closing Bell at 4:00 PM ET. The company, which focuses on dermatology, wound care, and infectious disease, has received three FDA clearances and is advancing late-stage clinical programs. It also pursues global health initiatives in vaccine deli...
10-08 12:00
Royce Global Trust (NYSE: RGT) as of Aug 31, 2025
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 63,386 shares Fun...
09-26 01:22
诺禾致源助力科研团队再登Cell顶刊｜植物单细胞测序技术突破引领基因发现新格局
2025年8月18日，中国科学院分子植物科学卓越创新中心王佳伟研究团队在国际顶级学术期刊Cell（影响因子42.5）发表了题为“A unified cell ...
09-22 17:48
Mount Logan And 180 Degree Capital Complete Merger; Mount Logan Capital Inc. To Trade As 'MLCI' On Nasdaq
Establishes U.S.-based alternative asset management and insurance solutions platformMerged Company, Mount Logan Capital Inc., expected to begin trading on NASDAQ under the symbol "MLCI" on Monday, September 15,
09-13 03:17
